Efficacy and Safety of Extended Treatment with Aficamten in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From FOREST-HCM
Efficacy and Safety of Extended Treatment with Aficamten in Patie…
8 months ago
marketscreener.com
Impact of Aficamten on Obstructive Hypertrophic Cardiomyopathy The SEQUOIA-HCM study highlights the significant benefits of Aficamten in treating obstructive hypertrophic cardiomyopathy (oHCM). Key findings include: Symptom Relief: Nearly all patients (97%) experienced clinically meaningful improvements in symptoms. Hemodynamic Response: Significant reduction in left ventricular outflow tract (LVOT) gradients. Exercise Capacity: Enhanced exercise capacity and reduced symptom burden. Cardiac Remo
2:30
Impact of Aficamten on Obstructive Hypertrophic Cardiomyopathy Th…
268 viewsSep 30, 2024
FacebookAbdallah Othman
SEQUOIA­HCM: Effect of aficamten treatment on patients with hypertrophic obstructive cardiomyopathy by geographical region discussed by Caroline Coats & Brenda Moura Hosted by Peter Paul Zwetsloot Watch their #HFASnacks 🤗 #HFA_ESC #HeartFailure2025 | European Society of Cardiology
6:00
SEQUOIA­HCM: Effect of aficamten treatment on patients with hypertr…
565 viewsMay 18, 2025
FacebookEuropean Society of Cardiology
Aficamten for Obstructive Hypertrophic Cardiomyopathy | NEJM
2:37
Aficamten for Obstructive Hypertrophic Cardiomyopathy | N…
6.3K viewsMay 30, 2024
YouTubeNEJM Group
Cytokinetics informiert über aktuellen Stand des Zulassungsantrags für Aficamten bei obstruktiver hypertropher Kardiomyopathie
Cytokinetics informiert über aktuellen Stand des Zulassungsan…
8 months ago
marketscreener.com
How Aficamten Works in Obstructive Hypertrophic Cardiomyopathy (HCM)
5:51
How Aficamten Works in Obstructive Hypertrophic Cardiom…
264 views4 months ago
YouTubePharmacology Insights
Cytokinetics CEO on shares soaring, heart drug Aficamten and American heart health - The Global Herald
Cytokinetics CEO on shares soaring, heart drug Aficamten an…
8 months ago
theglobalherald.com
Advies - wel of niet vergoeden aficamten (Myqorzo®) voor de beh…
1 month ago
zorginstituutnederland.nl
5:08
Cytokinetics CEO on shares soaring, heart drug Aficamten an…
Dec 28, 2023
CNBC
6:22
Martin Maron discusses aficamten for the treatment of symptomatic …
466 viewsMay 13, 2024
FacebookEuropean Society of Cardiology
MYQORZO (aficamten)- Cardiomyopathy | Saro Arakelians
24.4K views4 months ago
linkedin.com
2:42
Munir Janmohamed MD FACC FHFSA on Instagram: "💊 Aficamten …
1.2K views4 months ago
Instagramdrmunirjanmohamed
0:54
Aficamten: A New Cardiac Myosin Inhibitor for Hypertrophic Obstruc…
536 viewsMay 15, 2024
YouTubeJohnson's Cardiology മലയാളം
2:06
Aficamten: A New Cardiac Myosin Inhibitor for Hypertrophic Obstruc…
265 viewsMay 15, 2024
YouTubeJohnson's Cardiology മലയാളം
Lancement d'Aficamten par Cytokinetics en 2026 : une stratégi…
6 months ago
zonebourse.com
8:48
US FDA Approved MYQORZO (aficamten), a New Cardiac Myosi…
33 views3 months ago
YouTubeMedication Academy
1:52
A summary of SEQUOIA-HCM: A clinical study of aficamten for obs…
131 views6 months ago
YouTubeVideo Journal of Biomedicine
1:00
Aficamten: One More Cardiac Myosin Inhibitor for HOCM
728 viewsMay 15, 2024
YouTubeJohnson's Cardiology
3:00
Aficamten: One More Cardiac Myosin Inhibitor for HOCM
571 viewsMay 15, 2024
YouTubeJohnson's Cardiology
ACC 2023: Aficamten in Patients with Symptomatic Non-Obstructiv…
332 viewsMar 27, 2023
vumedi.com
7:08
HCM in Two Acts 🎭: Aficamten, Mavacamten & Dueling Data in th…
57 views8 months ago
YouTubeMasterMedFacts
0:23
Practice-changing: Cardiac myosin inhibitors redefine first-line oHCM …
2.3K views8 months ago
FacebookAbdallah Othman
19:16
Lisa and Dr. Maron discuss the FDA label for aficamten. | Hypertrophic …
1.8K views5 months ago
FacebookHypertrophic Cardiomyopathy Association
5:37
HFSA 25: 96-week Analysis from FOREST-HCM
94 views7 months ago
YouTubeRadcliffe Cardiology
3:01
AHA 25: MAPLE-HCM Responder Analysis: Aficamten Vs Metoprolo…
146 views6 months ago
YouTubeRadcliffe Cardiology
59:30
Making Strides in Hypertrophic Cardiomyopathy: Guidelines, Scie…
2.8K viewsMar 2, 2022
YouTubePeerView CME
3:02
MYQORZO (aficamten)- Cardiomyopathy
161 views5 months ago
YouTubePharmacy Talk USA
49:19
Strategies for Improving Outcomes in Hypertrophic Cardiomyopathy
1.7K viewsJun 2, 2022
YouTubePeerView CME
4:08
Why Myqorzo (aficamten) FDA Approval Is a Game Changer ? | C…
21 views4 months ago
YouTubeRxIndianPharmacist | Med Info | US Pharmacy …
Congratulations to Biocom California member Cytokinetics an…
5 months ago
linkedin.com
See more videos
Static thumbnail place holder